• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment


3.8000 USD 0.0500 1.30%

As of 20:10:00 ET on 07/22/2014.

Snapshot for Cerus Corp (CERS)

Open: 3.8700 Day's Range: 3.7900 - 3.9300 Volume: 1,139,063
Previous Close: 3.8500 52wk Range: 3.6600 - 8.0000 1-Yr Rtn: -29.76%

Stock Chart for CERS

No chart data available.
  • CERS:US 3.8000
  • 1D
  • 1M
  • 1Y
Interactive CERS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4839
Est. EPS (USD) (12/2014) -0.4860
Est. PEG Ratio -
Market Cap (M USD) 275.55
Shares Outstanding (M) 72.51
30 Day Average Volume 617,652
Price/Book (mrq) 6.1415
Price/Sale (ttm) 7.0898
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CERS

Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.

William Mariner Greenman "Obi"President/CEOChrystal N MenardChief Legal Officer
Caspar HogeboomPres:Cerus EuropeLaurence M CorashSenior VP/Chief Medical Ofcr/Co-Founder
More Company Profile & Key Executives for CERS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil